Luciana Bueno De Paiva, Vanessa Aline Bernusso, João Agostinho Machado-Neto, Fabiola Traina, Anne J Ridley, Sara Teresinha Olalla-Saad, Mariana Lazarini
{"title":"RhoA 和 RhoC 对前列腺癌细胞对谷氨酰胺剥夺敏感性的影响。","authors":"Luciana Bueno De Paiva, Vanessa Aline Bernusso, João Agostinho Machado-Neto, Fabiola Traina, Anne J Ridley, Sara Teresinha Olalla-Saad, Mariana Lazarini","doi":"10.1080/21541248.2018.1546098","DOIUrl":null,"url":null,"abstract":"<p><p>RhoA and RhoC contribute to the regulation of glutamine metabolism, which is a crucial determinant of cell growth in some types of cancer. Here we investigated the participation of RhoA and RhoC in the response of prostate cancer cells to glutamine deprivation. We found that RhoA and RhoC activities were up- or downregulated by glutamine reduction in PC3 and LNCaP cell lines, which was concomitant to a reduction in cell number and proliferation. Stable overexpression of wild type RhoA or RhoC did not alter the sensitivity to glutamine deprivation. However, PC3 cells expressing dominant negative RhoA<sup>N19</sup> or RhoC<sup>N19</sup> mutants were more resistant to glutamine deprivation. Our results indicate that RhoA and RhoC activities could affect cancer treatments targeting the glutamine pathway.</p>","PeriodicalId":22139,"journal":{"name":"Small GTPases","volume":"12 1","pages":"20-26"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781845/pdf/KSGT_12_1546098.pdf","citationCount":"0","resultStr":"{\"title\":\"Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation.\",\"authors\":\"Luciana Bueno De Paiva, Vanessa Aline Bernusso, João Agostinho Machado-Neto, Fabiola Traina, Anne J Ridley, Sara Teresinha Olalla-Saad, Mariana Lazarini\",\"doi\":\"10.1080/21541248.2018.1546098\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>RhoA and RhoC contribute to the regulation of glutamine metabolism, which is a crucial determinant of cell growth in some types of cancer. Here we investigated the participation of RhoA and RhoC in the response of prostate cancer cells to glutamine deprivation. We found that RhoA and RhoC activities were up- or downregulated by glutamine reduction in PC3 and LNCaP cell lines, which was concomitant to a reduction in cell number and proliferation. Stable overexpression of wild type RhoA or RhoC did not alter the sensitivity to glutamine deprivation. However, PC3 cells expressing dominant negative RhoA<sup>N19</sup> or RhoC<sup>N19</sup> mutants were more resistant to glutamine deprivation. Our results indicate that RhoA and RhoC activities could affect cancer treatments targeting the glutamine pathway.</p>\",\"PeriodicalId\":22139,\"journal\":{\"name\":\"Small GTPases\",\"volume\":\"12 1\",\"pages\":\"20-26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781845/pdf/KSGT_12_1546098.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Small GTPases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/21541248.2018.1546098\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/11/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Small GTPases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21541248.2018.1546098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/11/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation.
RhoA and RhoC contribute to the regulation of glutamine metabolism, which is a crucial determinant of cell growth in some types of cancer. Here we investigated the participation of RhoA and RhoC in the response of prostate cancer cells to glutamine deprivation. We found that RhoA and RhoC activities were up- or downregulated by glutamine reduction in PC3 and LNCaP cell lines, which was concomitant to a reduction in cell number and proliferation. Stable overexpression of wild type RhoA or RhoC did not alter the sensitivity to glutamine deprivation. However, PC3 cells expressing dominant negative RhoAN19 or RhoCN19 mutants were more resistant to glutamine deprivation. Our results indicate that RhoA and RhoC activities could affect cancer treatments targeting the glutamine pathway.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
